TCGA pan-cancer and reverse transcription-quantitative polymerase chain reaction analyses (RT-PCR) revealed that osimertinib-resistant cells concurrently exhibited over-expression of YAP/TAZ target genes [46]. Here, YAP1 is linked to cancer.